基于机器学习的标准组织学图像肿瘤浸润淋巴细胞评估与非小细胞肺癌患者免疫治疗结局的关联
这项多中心回顾性发现-验证队列研究纳入685例接受免疫检查点抑制剂治疗的非小细胞肺癌患者,开发基于机器学习的肿瘤浸润淋巴细胞自动评分方法,发现高TIL水平(≥250 cells/mm2)与无进展生存和总生存改善独立相关,在PD-L1阴性亚组中TIL对免疫治疗反应的分类准确性优于TMB。
要点
- 高TIL水平(≥250 cells/mm2)与免疫检查点抑制剂治疗反应独立相关,发现队列PFS HR 0.71、OS HR 0.74。
- 验证队列中高TIL水平同样与PFS(HR 0.80)和OS(HR 0.75)改善相关。
- PD-L1阴性(<1%)亚组中TIL对免疫治疗反应的分类准确性(AUC=0.77)优于TMB(AUC=0.65)。
核心结论
- 在这些队列中,TIL水平与免疫检查点抑制剂治疗反应稳健且独立相关。
- 患者TIL评估相对容易纳入病理实验室工作流程且额外成本极低,可能提升精准治疗。
研究设计与样本
- 多中心回顾性发现-验证队列研究,纳入685例接受抗PD-(L)1单药治疗的晚期非小细胞肺癌患者。
- 发现队列446例,中位随访38.1个月;验证队列239例,中位随访43.3个月。
- 患者治疗时间为2014年2月至2021年9月,数据分析时间为2021年6月至2022年4月。
- 开发机器学习自动方法计数全切片苏木精-伊红染色图像中的肿瘤、间质和TIL细胞。
- TMB和PD-L1表达分别评估,免疫治疗临床反应通过病历回顾确定。
主要发现
- 发现队列中女性248例(56%),验证队列中女性97例(41%)。
- 多变量分析中,高TIL水平(≥250 cells/mm2)在发现队列与ICI反应独立相关(PFS:HR 0.71,P=.006;OS:HR 0.74,P=.03)。
- 验证队列中高TIL水平与ICI反应独立相关(PFS:HR 0.80,P=.01;OS:HR 0.75,P=.001)。
- 一线和后续线ICI治疗患者均可见生存获益。
- 发现队列中,TILs/PD-L1或TMB/PD-L1联合模型较单用PD-L1在区分ICI反应者方面具有额外特异性。
关键数值与推荐
- 高TIL水平定义为≥250 cells/mm2。
- 发现队列PFS:HR 0.71(P=.006);OS:HR 0.74(P=.03)。
- 验证队列PFS:HR 0.80(P=.01);OS:HR 0.75(P=.001)。
- PD-L1阴性(<1%)亚组TIL分类AUC=0.77,TMB分类AUC=0.65。
临床怎么用
- 患者TIL评估相对容易纳入病理实验室工作流程且额外成本极低,可能提升精准治疗。
- 原文未据此给出具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Currently, predictive biomarkers for response to immune checkpoint inhibitor (ICI) therapy in lung cancer are limited. Identifying such biomarkers would be useful to refine patient selection and guide precision therapy. OBJECTIVE: To develop a machine-learning (ML)-based tumor-infiltrating lymphocytes (TILs) scoring approach, and to evaluate TIL association with clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC). DESIGN, SETTING, AND PARTICIPANTS: This multicenter retrospective discovery-validation cohort study included 685 ICI-treated patients with NSCLC with median follow-up of 38.1 and 43.3 months for the discovery (n = 446) and validation (n = 239) cohorts, respectively. Patients were treated between February 2014 and September 2021. We developed an ML automated method to count tumor, stroma, and TIL cells in whole-slide hematoxylin-eosin-stained images of NSCLC tumors. Tumor mutational burden (TMB) and programmed death ligand-1 (PD-L1) expression were assessed separately, and clinical response to ICI therapy was determined by medical record review. Data analysis was performed from June 2021 to April 2022. EXPOSURES: All patients received anti-PD-(L)1 monotherapy. MAIN OUTCOMES AND MEASURES: Objective response rate (ORR), progression-free survival (PFS), and overall survival (OS) were determined by blinded medical record review. The area under curve (AUC) of TIL levels, TMB, and PD-L1 in predicting ICI response were calculated using ORR. RESULTS: Overall, there were 248 (56%) women in the discovery cohort and 97 (41%) in the validation cohort. In a multivariable analysis, high TIL level (≥250 cells/mm2) was independently associated with ICI response in both the discovery (PFS: HR, 0.71; P = .006; OS: HR, 0.74; P = .03) and validation (PFS: HR = 0.80; P = .01; OS: HR = 0.75; P = .001) cohorts. Survival benefit was seen in both first- and subsequent-line ICI treatments in patients with NSCLC. In the discovery cohort, the combined models of TILs/PD-L1 or TMB/PD-L1 had additional specificity in differentiating ICI responders compared with PD-L1 alone. In the PD-L1 negative (<1%) subgroup, TIL levels had superior classification accuracy for ICI response (AUC = 0.77) compared with TMB (AUC = 0.65). CONCLUSIONS AND RELEVANCE: In these cohorts, TIL levels were robustly and independently associated with response to ICI treatment. Patient TIL assessment is relatively easily incorporated into the workflow of pathology laboratories at minimal additional cost, and may enhance precision therapy.
引用
- Rakaee M, Adib E, Ricciuti B, et al. Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC. JAMA Oncol. 2023. PMID: 36394839. doi:10.1001/jamaoncol.2022.4933
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。